Immunocore Holdings plc

IMCR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$32.43-4.08%

2026-08-03

Financials

Valuation Metrics

Immunocore Holdings plc's Market Cap is $1.65B. At end of 2025 it was $1.75B. Ranked #2191 of 3,112 in US market (top 70%), #862 of 1,445 on NASDAQ (top 60%), #157 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 58%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.65B	US#2,191/3,112 Sec#157/269
Revenue	$386M	US#2,454/3,112 Sec#89/269
Net Income	$-19M	US—/3,112 Sec—/269
Total Assets	$1.07B	US#2,417/3,112 Sec#94/269
Net Assets	$394M	US#2,417/3,112 Sec#135/269
Value
P/B	4.19x	US#2,020/3,112 Sec#124/269
P/S	4.28x	US#2,143/3,112 Sec#68/269
EV/EBITDA	261.61x	US#2,485/3,112 Sec#89/269
FCF Yield	-1.86%	US—/3,112 Sec—/269
Profitability
ROE	-4.78%	US#2,307/3,112 Sec#83/269
ROA	-1.76%	US#2,358/3,112 Sec#84/269
Op. Margin	-7.61%	US#2,608/3,112 Sec#95/269
Revenue Growth	13.63%	US#1,039/3,112 Sec#87/269
Earnings Growth	158.23%	US#243/3,112 Sec#10/269
Financial Health
Debt Ratio	172.33%	US#1,648/3,112 Sec#193/269
Total Debt	$436M	US#1,879/3,112 Sec#62/269
FCF	$-31M	US#2,411/3,112 Sec#102/269
Cash	$453M	US#1,134/3,112 Sec#60/269
Current Ratio	4.18x	US#575/3,112 Sec#164/269
Net Debt/EBITDA	-2.72x	US#139/3,112 Sec#9/269
Performance
1Y Return	-1.70%	US#2,089/3,112 Sec#194/269
1M Return	-0.22%	US#1,681/3,112 Sec#79/269
From 52W High	-20.34%	US#1,744/3,112 Sec#110/269
1Y MDD	-30.91%	US#1,451/3,112 Sec#89/269
Trading
Volume	632,036 shares	US#1,888/3,112 Sec#186/269
Trading Value	$21M	US#1,933/3,112 Sec#141/269
Per Share
EPS	$-0.53	US—/3,112 Sec—/269
BPS	$7.57	US#1,984/3,112 Sec#94/269